Suchergebnisse - (Subject:"Prednisone")

PubPharm (1.905)

1

Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience

enthalten in: Annals of hematology | 2024

von Qin, S. | Jiang, R. | Dai, L. | +11

2

Treatment patterns and costs among US patients with diffuse large B-cell lymphoma not treated with 2L stem cell transplantation

enthalten in: Future oncology (London, England) | 2024

von Acheampong, T. | Gu, T. | Le, T. | +1

3

Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray

enthalten in: Cancer | 2024

von Dai, L. | Chen, H. | Tan, Q. | +14

4

R-CHOP treatment for patients with advanced follicular lymphoma : Over 15-year follow-up of JCOG0203

enthalten in: British journal of haematology | 2024

von Watanabe, T. | Tobinai, K. | Wakabayashi, M. | +13

5

Pembrolizumab With R-CHOP in Previously Untreated DLBCL : Sustained, High Efficacy, and Safety With Long-Term Follow-Up

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Ho, C. | Gopal, A. | Till, B. | +12

6

R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma : A propensity matched population-based study

enthalten in: American journal of hematology | 2024

von Al-Sarayfi, D. | Brink, M. | Chamuleau, M. | +11

7

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma : Pathogenesis and Patient Outcomes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Noerenberg, D. | Briest, F. | Hennch, C. | +30

8

Prognostic impact of absolute peripheral blood NK cell count after four cycles of R-CHOP-like regimen treatment in patients with diffuse large B cell lymphoma

enthalten in: Clinical and experimental medicine | 2023

von Huo, Z. | Chen, F. | Zhao, J. | +11

9

Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Burke, J. | Masaquel, A. | Wang, R. | +5

10

Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL : the phase 1b First-MIND study

enthalten in: Blood | 2023

von Belada, D. | Kopeckova, K. | Bergua Burgues, J. | +13

CommentIn: Blood. 2023 Oct 19;142(16):1331-1332. - PMID 37856095

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[191]